Intelligence · Clinical Development
Pipeline search results
Programs matching “febuxostat” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 16 pipeline programs matching "febuxostat" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Febuxostat
Takeda
Cardiovascular Disease
1 trial -
Febuxostat IR
Takeda
Gout
2 trials -
FEBUXOSTAT, ALLOPURINOL
Pari Pharma GmbH
Gout adult patients
1 trial -
Febuxostat
Takeda
Hypertension
1 trial -
Febuxostat
Takeda
Angina
1 trial -
Febuxostat
Takeda
Hyperuricosuria
1 trial -
Febuxostat
Takeda
Joint Damage
1 trial -
Febuxostat
Takeda
Renal Impairment
1 trial -
Febuxostat XR
Takeda
Healthy Volunteers
1 trial -
Febuxostat XR
Takeda
Gout
1 trial -
Febuxostat XR 80 mg Capsule F1
Takeda
Healthy Volunteers
1 trial -
20mg Febuxostat
The First People's Hospital of Lianyungang
Hyperuricemia
1 trial -
Febuxostat
Takeda
Gout
6 trials -
Febuxostat
Takeda
Coronary Artery Disease
1 trial -
Febuxostat
Takeda
Chronic Kidney Disease
1 trial -
Febuxostat
The First People's Hospital of Lianyungang
Refractory Gout
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.